We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Diabetes & Endocrinology

Diabetes & Endocrinology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

LC-MS/MS Redefines Accuracy in Congenital Adrenal Hyperplasia Newborn Screening: Reducing the False-Positive Burden
Diabetes & Endocrinology17-hydroxyprogesterone先天性肾上腺皮质增生症,住院,肾上腺危象,流行病学,内分泌学

LC-MS/MS Redefines Accuracy in Congenital Adrenal Hyperplasia Newborn Screening: Reducing the False-Positive Burden

By MedXY|Mar 12, 2026

A prospective study of over 700,000 newborns demonstrates that LC-MS/MS significantly improves the positive predictive value (PPV) of CAH screening compared to traditional RIA, identifying specific steroid ratios that offer 100% PPV and red

Lifestyle Determinants and Metabolic Compensation in Pregnancies Complicated by Type 1 Diabetes: A Synthesis of the ENDIA Study and Recent Evidence
Clinical UpdatesIslet Autoimmunitynutrition

Lifestyle Determinants and Metabolic Compensation in Pregnancies Complicated by Type 1 Diabetes: A Synthesis of the ENDIA Study and Recent Evidence

By MedXY|Mar 13, 2026

This review analyzes the lifestyle patterns of pregnant women with type 1 diabetes, synthesizing findings from the ENDIA study with recent evidence on nutritional adequacy, islet autoimmunity, and the molecular mechanisms of metabolic compe

Relacorilant Demonstrates Sustained Efficacy in Hypertension Control for Patients with Cushing’s Syndrome: Results from the Phase 3 GRACE Study
Diabetes & EndocrinologyCushing's SyndromeGlucocorticoid Receptor

Relacorilant Demonstrates Sustained Efficacy in Hypertension Control for Patients with Cushing’s Syndrome: Results from the Phase 3 GRACE Study

By MedXY|Mar 12, 2026

The Phase 3 GRACE trial demonstrates that relacorilant, a selective glucocorticoid receptor modulator, significantly maintains hypertension control in patients with Cushing’s syndrome without the safety concerns associated with non-selectiv

GLP-1 Receptor Agonists in Primary Prevention: Emulated Clinical Trial Predicts 22% Reduction in Cardiovascular Events
Cardiologycardiovascular diseaseGLP-1RA

GLP-1 Receptor Agonists in Primary Prevention: Emulated Clinical Trial Predicts 22% Reduction in Cardiovascular Events

By MedXY|Mar 12, 2026

This emulation study applies SELECT trial data to over 600,000 individuals, suggesting that GLP-1RAs could significantly reduce 10-year cardiovascular risk in high-risk obese populations without existing disease, offering a potential 22% re

Distinctive Endocrine Profiles and Hyperphagia in Rare Genetic Neurodevelopmental Disorders: Beyond the Prader-Willi Paradigm
Clinical UpdatesGhrelinHội chứng Prader-Willi

Distinctive Endocrine Profiles and Hyperphagia in Rare Genetic Neurodevelopmental Disorders: Beyond the Prader-Willi Paradigm

By MedXY|Mar 11, 2026

This review synthesizes findings from a national multicenter study identifying that hyperghrelinemia is a specific biomarker for Prader-Willi Syndrome, whereas other rare neurodevelopmental disorders exhibit normal ghrelin levels despite se

Enhancing Health-Economic Evaluation in Thyroid Oncology: Development and Valuation of the Thyroid Cancer Quality of Life Index (TCQOLI)
Clinical Updateshealth economicsHRQoL

Enhancing Health-Economic Evaluation in Thyroid Oncology: Development and Valuation of the Thyroid Cancer Quality of Life Index (TCQOLI)

By MedXY|Mar 11, 2026

This review details the development and psychometric validation of the TCQOLI, a novel thyroid-cancer-specific utility measure designed to provide precise preference-based health state valuations for clinical research and policy-making.

Beyond Height Velocity: Longitudinal Impact of Long-Acting Growth Hormone on Body Mass Index in Pediatric Growth Hormone Deficiency
Clinical UpdatesBMIGHD

Beyond Height Velocity: Longitudinal Impact of Long-Acting Growth Hormone on Body Mass Index in Pediatric Growth Hormone Deficiency

By MedXY|Mar 11, 2026

This meta-analysis reveals that long-acting growth hormone (LAGH) is associated with a significant increase in BMI SD scores during the first year of treatment and upon switching from daily GH, suggesting a distinct metabolic profile compar

Maternal Glycemic Control in Gestational Diabetes and Its Impact on Childhood Obesity
Diabetes & Endocrinologychildhood obesityGestational Diabetes

Maternal Glycemic Control in Gestational Diabetes and Its Impact on Childhood Obesity

By MedXY|Mar 11, 2026

Research indicates that achieving stable and optimal blood sugar levels immediately after a gestational diabetes diagnosis can reduce a child’s risk of obesity to levels comparable to those born to mothers without the condition.

The Interplay of Aging and Chronic Iodine Excess on Thyrotropin Dynamics: A 20-Year Longitudinal Synthesis
Clinical UpdatesagingDịch tễ học Tuyến giáp

The Interplay of Aging and Chronic Iodine Excess on Thyrotropin Dynamics: A 20-Year Longitudinal Synthesis

By MedXY|Mar 11, 2026

This review analyzes a landmark 20-year study highlighting how chronic iodine excess and aging synergistically elevate TSH levels, revealing that iodine-induced thyroid changes persist even after dietary reduction.

Chrono-Nutrition in Gestational Diabetes: Impact of Early Meal Timing on Nocturnal Glycemic Control
Clinical UpdatesChrono-Nutritioncircadian rhythm

Chrono-Nutrition in Gestational Diabetes: Impact of Early Meal Timing on Nocturnal Glycemic Control

By MedXY|Mar 11, 2026

This review synthesizes recent evidence demonstrating that early morning meal timing significantly improves nocturnal glucose profiles in gestational diabetes, offering a novel lifestyle intervention for metabolic management.

OGTT-Derived Surrogate Indexes Outperform Fasting Measures in Predicting Type 2 Diabetes Risk: A Longitudinal Analysis
Diabetes & Endocrinologyinsulin resistanceOGTT

OGTT-Derived Surrogate Indexes Outperform Fasting Measures in Predicting Type 2 Diabetes Risk: A Longitudinal Analysis

By MedXY|Mar 10, 2026

A longitudinal study of 2,260 participants confirms that oral glucose tolerance test (OGTT)-based surrogate indexes, particularly Gutt and Cederholm, are superior to fasting-only measures in predicting type 2 diabetes, providing high clinic

Decoding Glycemic Control in Dialysis: Why HbA1c and Glycated Albumin Require a Nuanced Approach
Diabetes & Endocrinologycontinuous glucose monitoringGlycemic Control

Decoding Glycemic Control in Dialysis: Why HbA1c and Glycated Albumin Require a Nuanced Approach

By MedXY|Mar 10, 2026

This study evaluates HbA1c, glycated albumin, and fructosamine against CGM in dialysis patients. While HbA1c and glycated albumin show strong correlations with mean glucose, significant clinical biases from ESA use, BMI, and dialysis modali

Beyond Thyroglobulin: Uncovering the Alternative Path for Thyroid Hormone Synthesis
Diabetes & EndocrinologyendocrinologyThyroglobulin

Beyond Thyroglobulin: Uncovering the Alternative Path for Thyroid Hormone Synthesis

By MedXY|Mar 10, 2026

This study explores how the body synthesizes thyroid hormones without thyroglobulin, the primary precursor protein. Research using Tg-KO mice reveals an inefficient but life-sustaining mechanism involving goiter growth and the iodination of

Leveling the Playing Field: New Trans-Ancestry Polygenic Risk Score Transforms Type 1 Diabetes Screening
Diabetes & Endocrinologygenomicshealth equity

Leveling the Playing Field: New Trans-Ancestry Polygenic Risk Score Transforms Type 1 Diabetes Screening

By MedXY|Mar 10, 2026

Researchers have developed a trans-ancestry polygenic risk score (TA-PS) that significantly improves the accuracy of type 1 diabetes prediction across diverse ethnic groups, addressing the long-standing European bias in genetic risk assessm

Elevated MCP1 and FABP4 in Early PCOS Pregnancy: Metabolic Markers Driven by Adiposity Rather Than Disease Status
Diabetes & EndocrinologyAdiposityPCOS

Elevated MCP1 and FABP4 in Early PCOS Pregnancy: Metabolic Markers Driven by Adiposity Rather Than Disease Status

By MedXY|Mar 10, 2026

A cross-sectional study reveals that while MCP1 and FABP4 are elevated in early pregnancy among women with PCOS, these biomarkers primarily reflect maternal adiposity and do not independently predict adverse outcomes, highlighting the impor

Early Antenatal Prediabetes: A Critical Red Flag for Rapid Postpartum Progression to Type 2 Diabetes
Diabetes & EndocrinologyGestational DiabetesHbA1c

Early Antenatal Prediabetes: A Critical Red Flag for Rapid Postpartum Progression to Type 2 Diabetes

By MedXY|Mar 10, 2026

A multiethnic New Zealand **Synthesizing Article Draft** I’m now fully immersed in writing the article. I’m focusing on the “Introduction/Highlight,” integrating the essential findings regarding HbA1c, BMI, and Pacif

Semaglutide Drives Vascular Regeneration: The SEMA-VR CardioLink-15 Trial Reveals a Shift in Progenitor Cell Flux
CardiologyASCVDGLP-1 receptor agonists

Semaglutide Drives Vascular Regeneration: The SEMA-VR CardioLink-15 Trial Reveals a Shift in Progenitor Cell Flux

By MedXY|Mar 9, 2026

The SEMA-VR CardioLink-15 trial demonstrates that semaglutide shifts bone marrow-derived progenitor cells toward an anti-inflammatory, pro-regenerative profile, potentially enhancing endogenous vessel repair in high-risk cardiovascular pati

Taurochenodeoxycholic Acid: A Novel Metabolic Sentinel Reversing Obesity-Induced Endothelial Dysfunction via the FXR-PHB1-ATF4 Axis
Cardiologybile acidsendothelial dysfunction

Taurochenodeoxycholic Acid: A Novel Metabolic Sentinel Reversing Obesity-Induced Endothelial Dysfunction via the FXR-PHB1-ATF4 Axis

By MedXY|Mar 9, 2026

This study identifies TCDCA as a key metabolite that restores endothelial function in obesity. By activating the endothelial FXR-PHB1-ATF4 pathway, TCDCA enhances serine metabolism, offering a promising therapeutic strategy to mitigate card

High-Intensity Interval Training Restores Mitochondrial Architecture in Type 2 Diabetes via Cristae Remodeling
Diabetes & EndocrinologyHIITtype 2 diabetes

High-Intensity Interval Training Restores Mitochondrial Architecture in Type 2 Diabetes via Cristae Remodeling

By MedXY|Mar 9, 2026

A breakthrough study demonstrates that high-intensity interval training (HIIT) significantly enhances mitochondrial cristae density and surface area in men with type 2 diabetes, revealing remarkable plasticity in muscle ultrastructure despi

Management of Graves’ Disease During Pregnancy: Clinical Insights from the Danish PRETHYR Multicenter Study
Clinical UpdatesendocrinologyGraves' Disease

Management of Graves’ Disease During Pregnancy: Clinical Insights from the Danish PRETHYR Multicenter Study

By MedXY|Mar 9, 2026

This clinical review synthesizes findings from the PRETHYR study on antithyroid drug use in pregnant women, highlighting treatment transitions, biochemical predictors, and the impact of specialist-led management in Denmark.

Prev
23 / 25
1…2122232425
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles